Skip to content

CRH Medical Corp: 10-Q filed 2020-11-12

What CRH Medical Corp reported in its quarterly report filed 2020-11-12 (fiscal Q3 2020): 39 published measures, 125 facts as tagged in accession 0001564590-20-053624.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-12
Fiscal period
fiscal Q3 2020
Accession
0001564590-20-053624 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CRH Medical Corp filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-30214,247,193USD
At 2019-12-31203,095,269USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-3072,273,644USD
At 2019-12-3176,312,478USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-305,099,498USD
At 2019-12-316,568,716USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-07-01 to 2020-09-307,816,677USD92
2020-01-01 to 2020-09-3024,795,713USD274
2019-07-01 to 2019-09-3010,711,163USD92
2019-01-01 to 2019-09-3032,669,879USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-07-01 to 2020-09-3010,957USD92
2020-01-01 to 2020-09-3032,829USD274
2019-07-01 to 2019-09-304,834USD92
2019-01-01 to 2019-09-3045,681USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-07-01 to 2020-09-3030,349,452USD92
2020-01-01 to 2020-09-3069,389,150USD274
2019-07-01 to 2019-09-3030,414,803USD92
2019-01-01 to 2019-09-3090,016,052USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-07-01 to 2020-09-305,039,073USD92
2020-01-01 to 2020-09-30-4,727,879USD274
2019-07-01 to 2019-09-30-10,376,269USD92
2019-01-01 to 2019-09-30-32,611,017USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-12,995,448USD92
2020-01-01 to 2020-09-30-21,537,585USD274
2019-07-01 to 2019-09-302,318,000USD92
2019-01-01 to 2019-09-30-4,792,158USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-307,423,053USD
At 2019-12-3113,154,981USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2020-07-01 to 2020-09-3071,506,045shares92
2020-01-01 to 2020-09-3071,558,371shares274
2019-07-01 to 2019-09-3071,831,356shares92
2019-01-01 to 2019-09-3071,845,812shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2020-07-01 to 2020-09-3071,506,045shares92
2020-01-01 to 2020-09-3071,558,371shares274
2019-07-01 to 2019-09-3072,799,142shares92
2019-01-01 to 2019-09-3073,023,144shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-0.005USD/shares92
2020-01-01 to 2020-09-30-0.074USD/shares274
2019-07-01 to 2019-09-300.014USD/shares92
2019-01-01 to 2019-09-300.036USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-0.005USD/shares92
2020-01-01 to 2020-09-30-0.074USD/shares274
2019-07-01 to 2019-09-300.013USD/shares92
2019-01-01 to 2019-09-300.035USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-376,237USD92
2020-01-01 to 2020-09-30-1,584,165USD274
2019-07-01 to 2019-09-30565,165USD92
2019-01-01 to 2019-09-30736,052USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-30201,959USD
At 2019-12-31251,933USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-3084,827USD92
2020-01-01 to 2020-09-30-10,561,491USD274
2019-07-01 to 2019-09-303,712,626USD92
2019-01-01 to 2019-09-3012,124,607USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-3029,435,010USD
At 2019-12-3129,020,940USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-3011,193,960USD
At 2019-12-3110,343,442USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-307,449,298USD
At 2019-12-316,196,741USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-09-30296,070USD
At 2019-12-31349,324USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-3071,461,684shares
At 2019-12-3171,603,584shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-09-30-66,772USD
At 2019-12-31-66,772USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2020-09-30124,458,124USD
At 2020-06-30117,700,209USD
At 2020-03-31120,401,575USD
At 2019-12-31124,215,360USD
At 2019-09-30118,277,128USD
At 2019-06-30129,282,085USD
At 2019-03-31133,718,099USD
At 2018-12-31137,291,177USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-09-301,107,114USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2020-09-3075,848,120USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-09-30168,325,328USD
At 2019-12-31163,108,193USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-09-305,465,489USD
At 2019-12-314,983,465USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2020-09-3023,786USD
At 2019-12-31101,822USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-67,471USD92
2020-01-01 to 2020-09-30-6,838,849USD274
2019-07-01 to 2019-09-302,664,494USD92
2019-01-01 to 2019-09-306,844,848USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-07-01 to 2020-09-30308,766USD92
2020-01-01 to 2020-09-30-5,254,684USD274
2019-07-01 to 2019-09-302,099,329USD92
2019-01-01 to 2019-09-306,108,796USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-07-01 to 2020-09-30308,766USD92
2020-04-01 to 2020-06-30-3,428,492USD91
2020-01-01 to 2020-03-31-2,134,957USD91
2019-07-01 to 2019-09-302,099,329USD92
2019-04-01 to 2019-06-302,618,675USD91
2019-01-01 to 2019-03-311,390,790USD90

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-337,954USD92
2020-01-01 to 2020-09-30-5,324,264USD274
2019-07-01 to 2019-09-30982,368USD92
2019-01-01 to 2019-09-302,552,084USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2020-07-01 to 2020-09-3010,760,397USD92
2020-01-01 to 2020-09-3029,686,467USD274
2019-07-01 to 2019-09-308,555,909USD92
2019-01-01 to 2019-09-3025,974,283USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2020-01-01 to 2020-09-3029,603,482USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-07-01 to 2020-09-30479,023USD92
2020-01-01 to 2020-09-301,547,068USD274
2019-07-01 to 2019-09-30772,680USD92
2019-01-01 to 2019-09-302,532,084USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,291,679USD92
2020-01-01 to 2020-09-30-2,958,068USD274
2019-07-01 to 2019-09-30-1,359,634USD92
2019-01-01 to 2019-09-30-3,640,248USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2020-07-01 to 2020-09-3071,902USD92
2020-01-01 to 2020-09-30171,086USD274
2019-07-01 to 2019-09-3090,669USD92
2019-01-01 to 2019-09-30278,339USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-3031,017USD92
2020-01-01 to 2020-09-30-53,254USD274
2019-07-01 to 2019-09-30-153,837USD92
2019-01-01 to 2019-09-30-45,309USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-640,539USD92
2020-01-01 to 2020-09-303,192,069USD274
2019-07-01 to 2019-09-30-83,936USD92
2019-01-01 to 2019-09-3091,726USD273

Inspect the source

Entity
CRH Medical Corp / CIK 0001461119
Captured
SEC response SHA-256
d5f9a1924d8b91d369ab0823c8172fd4dacfff72a826dcf72d618bad3d939242

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001461119.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))